<SEC-DOCUMENT>0001193125-22-154415.txt : 20220519
<SEC-HEADER>0001193125-22-154415.hdr.sgml : 20220519
<ACCEPTANCE-DATETIME>20220519060552
ACCESSION NUMBER:		0001193125-22-154415
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20220519
DATE AS OF CHANGE:		20220519

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMERICAN VANGUARD CORP
		CENTRAL INDEX KEY:			0000005981
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE CHEMICALS [2870]
		IRS NUMBER:				952588080
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13795
		FILM NUMBER:		22941091

	BUSINESS ADDRESS:	
		STREET 1:		4695 MACARTHUR COURT
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92660
		BUSINESS PHONE:		949-260-1200

	MAIL ADDRESS:	
		STREET 1:		4695 MACARTHUR COURT
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92660

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AEROCON INC
		DATE OF NAME CHANGE:	19720620
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>d349121ddefa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<HTML><HEAD>
<TITLE>DEFA14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(Amendment No.&nbsp;&nbsp;&nbsp;&nbsp;) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&nbsp;&nbsp;&#9746; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by a Party other than the Registrant&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Preliminary Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>&#9744;<B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidential, for Use of the Commission Only (as permitted by Rule
<FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT> </B></P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Additional Materials </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting Material Pursuant to Rule <FONT STYLE="white-space:nowrap">14a-11(c)</FONT> or Rule <FONT
STYLE="white-space:nowrap">14a-12</FONT> </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>AMERICAN VANGUARD CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check all boxes that apply): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No fee required </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee paid previously with preliminary materials </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules
<FONT STYLE="white-space:nowrap">14a-6(i)(1)</FONT> and <FONT STYLE="white-space:nowrap">0-11</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g349121g0519075340485.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMERICAN VANGUARD DISCLOSES DETAILS OF BOARD REFRESHMENT PROCESS AND TIMELINE FOLLOWING CONTINUING
ENGAGEMENT WITH STOCKHOLDERS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Formalizes Process that Began in 2018; </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Company to Replace Two Incumbent Directors No Later Than the End of 2023 </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>AVD Continuing to Seek Stockholder Input Throughout Process </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Newport Beach, CA,</B> May&nbsp;19, 2022 &#151; American Vanguard Corporation (&#147;American Vanguard&#148; or &#147;the Company&#148;) (NYSE: AVD) today
disclosed the status and timeline of its ongoing process to refresh the Company&#146;s Board of Directors. The Company is engaged in a process to identify and appoint at least two new independent directors, one no later than the end of 2022 and the
other by the end of 2023. Both candidates would require expertise that would complement the Company&#146;s strategic growth plans. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Eric Wintemute,
Chairman and CEO of American Vanguard stated: &#147;In 2018, we began a process to refresh and increase the diversity of AVD&#146;s Board. We have added two new directors in the past three years and have been actively planning additional director
refreshment. Following discussions with numerous key stockholders over the past few months, AVD&#146;s Board unanimously determined it was in the best interests of all stockholders to provide investors with more clarity about our process, objectives
and approximate timeline for ongoing Board refreshment. Following this process allows AVD to enhance the skillsets and diversity of our Board, while minimizing the risk of disruption to our strategic plan, as we drive value creation for
stockholders.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Marisol Angelini, Independent Director, stated: &#147;We&#146;re encouraged by the feedback we&#146;ve received from stockholders to
date and look forward to continued engagement with them. We believe that the thorough process the Board has in place will result in new independent directors who are well suited to oversee the Company&#146;s next stage of growth.&#148; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Important Additional Information and Where to Find It </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">American Vanguard has filed a definitive proxy statement on Schedule 14A, and an accompanying <B><U>WHITE</U></B> proxy card, with the Securities and Exchange
Commission (&#147;SEC&#148;) in connection with the solicitation of proxies for its 2022 Annual Meeting of Stockholders. <B>STOCKHOLDERS ARE STRONGLY ADVISED TO READ THE COMPANY&#146;S DEFINITIVE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR
SUPPLEMENTS THERETO) AND ANY AND ALL OTHER DOCUMENTS FILED WITH THE SEC WHEN THEY BECOME AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION</B>. Stockholders may obtain a free copy of the proxy statement and accompanying <B><U>WHITE</U></B>
proxy card, any amendments or supplements to the proxy statement, and other documents that the Company files with the SEC, from the Company&#146;s website, https://www.american-vanguard.com, or from the SEC&#146;s website at http://www.sec.gov.
These will be available as soon as reasonably practicable after such materials are electronically filed with or furnished to the SEC. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Certain
Information Regarding Participants to the Solicitation </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company and its directors, executive officers and certain employees and other persons
may be deemed to be participants in the solicitation of proxies from the Company&#146;s stockholders in connection with the business to be conducted at the Annual Meeting. Stockholders may obtain information regarding the names, affiliations and
interests of the Company&#146;s directors and executive officers included in or incorporated by reference into the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2021,
which was filed with the SEC on March&nbsp;14, 2022, or from the Company&#146;s definitive proxy statement filed with the SEC on April&nbsp;29, 2022. To the extent the holdings of the Company&#146;s securities by the Company&#146;s directors and
executive officers have changed since the numbers set forth in the Company&#146;s definitive proxy statement, such changes have been or will be reflected on Statements of Change in Ownership on Form 4 filed with the SEC. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Forward-Looking Statements </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain information
set forth in this release and the accompanying letter may constitute &#147;forward looking statements&#148; within the meaning of federal and applicable state securities laws. All statements herein that are not statements of historical fact are
forward looking statements. These statements include statements regarding management&#146;s expectations for future performance, as well as descriptions of plans and strategies and the expected results thereof. Without limiting the generality of the
foregoing, statements about our expected ability to continue benefiting from the strategies developed and implemented by the Board and management, our ability timely to execute the annunciated board refreshment strategy, and statements about the
anticipated outcomes of these strategies, are forward looking in nature and should be interpreted accordingly. Statements about our projected stock price and the strategies that may lead to those prices are likewise forward-looking. These statements
reflect the current expectations of American Vanguard&#146;s management based on currently known facts and circumstances, and should not be construed as assurances of performance or as guaranties of the actual outcomes. Without limiting the
generality of the foregoing, forward looking statements include expectations about expected revenues, product margins, and net income, as well as factors relating to the effects on the Company&#146;s earnings of the contested proxy solicitation
currently underway. Actual results may differ from those expressed in forward looking statements, and those differences may be material and adverse. Factors that could cause actual results to differ from expectations include the ongoing effects of
the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic and government responses and economic conditions resulting therefrom; the effect of international exchange rates and other local, national and foreign economic conditions; weather and
climate conditions; changes </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in regulatory policy and in specific regulations and permitting processes that affect our products, and other risks as detailed from <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">time-to-time</FONT></FONT> in the Company&#146;s SEC reports and filings. The Company&#146;s Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the fiscal Quarter ended March&nbsp;31, 2022, filed
with the SEC on May&nbsp;4, 2022, contains a list of risk factors that may cause results to differ from expectations. These risk factors will be updated from time to time in accordance with the requirements of the Securities Exchange Act of 1934, as
amended, and the regulations thereunder (&#147;Exchange Act&#148;), or otherwise in our Exchange Act filings. The statements in this release speak only as of the date hereof, and the Company undertakes no duty to update such statements to reflect
future events or developments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About American Vanguard </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and
management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>&nbsp;and Russell
3000<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>&nbsp;Indexes and the Standard&nbsp;&amp; Poor&#146;s Small Cap 600 Index. To learn more about American Vanguard, please reference the Company&#146;s web site at
www.american-vanguard.com. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contact </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Reevemark </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Paul Caminiti/Nicholas Leasure </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(212) <FONT
STYLE="white-space:nowrap">433-4600</FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Paul.Caminiti@reevemark.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nicholas.Leasure@reevemark.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MacKenzie Partners, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Bob Marese </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(212)
<FONT STYLE="white-space:nowrap">929-5500</FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">bmarese@mackenziepartners.com </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g349121g0519075340485.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g349121g0519075340485.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !B 0H# 2(  A$! Q$!_\0
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M-\-HVB\:I&PPRHP(JAJ,=A+X\NTU)VCLS<-YC+U K9\$?\E(G_WI/YUD7_V
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M-'HKJ]L7))5MW-8WB#P_X0NK[&H-#;W3<G:^TG-5/A/_ ,BQ+_UW-<G\2O\
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M0R#*.I5A[&H+/!'OYM0\#06"DLUM==/]ENGZUZ6Y3P=\.,?=F\G'U=JM:9X
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
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
